News

eVionyx Awarded USDA Project

HAWTHORNE, NY (March 20, 2007) - The overall goal of this project is to develop a novel electrochemical approach of lignocellulose material destruction and delignfication to produce a safe, efficient, and inexpensive method to obtain highly digestible feedstuff from the lignocellulose materials.

Reveo, Inc. registers to compete in the $10M Archon Genomics X-Prize

ELMSFORD, NY (Mar 20, 2007) - Reveo, Inc. has registered to compete in the $10M Archon Prize for Genomics sponsored by the X-prize Foundation (www.xprize.org). This prize, which is the largest medical prize in history, will be awarded to the first team who can develop an instrument and use it to sequence 100 human genomes in 10 days, costing < $10,000/ genome, having an accuracy of 99.999% with 98% complete coverage.

Reveo, Inc. Announces a new figure of merit for DNA sequencing instruments at AGBT Conference.

ELMSFORD, NY (March 1, 2007) - Reveo recently attended the 8th Annual Advances in Genome Biology and Technology (AGBT) Conference in Marco Island, Florida (February 7-10, 2007) and presented a new figure of merit to objectively compare all sequencing instruments that is independent of the underlying technology. This figure of merit which incorporates the total cost to sequence an entire genome, total time to sequence an entire genome, cumulative errors generated during sequencing and comprehensiveness of the sequencing coverage is called the CTEC Index.

eVionyx, Inc. Receives ISO Certification for Its Manufacturing Facility in Taiwan.

HAWTHORNE, NY (January 10, 2007) - eVionyx, Inc. (www.evionyx.com), a Reveo subsidiary and the leader in innovative metal fuel cell technology and products, has built a comprehensive manufacturing facility in its subsidiary, eVionyx-Taiwan (www.evionyx-taiwan.com).

Reveo and the University of Washington to Develop Rapid DNA Sequencer Based on Novel Nano-Scale Phenomena.

BOSTON, MA (May 8, 2006) - Reveo, Inc. announces at NanoTech 2006 that it has teamed with the University of Washington to develop a breakthrough invention for rapid sequencing of DNA using novel nano-scale electronic and photonic effects that allow for bypassing many biochemical steps necessary in conventional DNA sequencing methods. The team will demonstrate proof of concept. The ultimate goal of this effort is to produce affordable and easy-to-use commercial products.

One more patent (U.S.6,875,671) issued to Reveo.

ELMSFORD, NY (April 5, 2006) - U.S. Patent No. 6,875,671 , entitled "Method of Fabricating Vertical Integrated Circuits" issued on April 5, 2005. Congratulations to Dr. Sadeg M. Faris. This patent adds to Reveo's portfolio in micro/nano-structures and processed for forming such micro/nano-structures. This patent adds to a very significant group of portfolios owned by Reveo including the fields of thin layer processing and vertically integrated devices.

One more patent (U.S.6,992,749) issued to Reveo.

ELMSFORD, NY (January 31, 2006) - U.S. Patent No. 6,992,749 , entitled "Scalable and Mass-Manufacturable OXC using Liquid Crystal" issued on January 31, 2006. Congratulations to Dr. Seungug Koh and Sadeg M. Faris. This patent is directed to a 1XN (or NX1) optical connector for steering light, useful in many communications and computing applications. A key advantage of this patent is the integration of components to form a monolithic structure.

One more patent (U.S.6,962,816) issued to Reveo.

ELMSFORD, NY (November 8, 2005) - U.S. Patent No. 6,962,816 , entitled "Highly Controllable Electroporation and Application Thereof" issued on November 8, 2005. Congratulations to Dr. Sadeg M. Faris. This patent adds to Reveo's portfolio in the field of biotechnology. Conventionally, electroporation is used in laboratory settings to inject chemical and biological compounds into a cell, avoiding the reliance on the cell's own protein receptors and trans-membrane channels for transport across the cell membrane.

Army Phase II Project titled “Compact Alkaline Fuel Cell System” granted on 11/2/05.

ELMSFORD, NY (November 2, 2005) - Reveo has been awarded an Army Phase II SBIR Project entitled “Compact Alkaline Fuel Cell System” granted on 11/2/05, following the successful completion of Phase I. The mission of this project is to develop a very high-energy density, light weight power source for communications and other advanced electronic devices, which is currently met with primary Li/SO2 (e.g. BA-55901) and secondary lithium ion batteries.

Army Phase II Project titled “Novel Oxygen Pump for High Altitude Air Breathing Engines” granted on 8/9/05.

ELMSFORD, NY (August 9, 2005) - Reveo has been awarded an Army Phase II SBIR Project entitled “Novel Oxygen Pump for High Altitude Air Breathing Engines” granted on 8/9/05, following the successful Phase I. The mission of this project is to develop an oxygen enrichment pump to aid in the efficiency of airplane engines when they reach extremely high altitudes, harnessing the electrochemistry expertise of Reveo and its subsidiary eVionyx.

Syndicate content